Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

WHO cautious on COVID-19 plasma as U.S. issues emergency authorization

Published 08/24/2020, 07:54 AM
Updated 08/24/2020, 07:55 AM
© Reuters. FILE PHOTO: Convalescent plasma from a recovered coronavirus disease (COVID-19) patient at Bloodworks Northwest during the outbreak in Seattle

(Reuters) - The World Health Organization on Monday was cautious about endorsing the use of recovered COVID-19 patients' plasma to treat people who are ill, saying evidence it works remains "low quality" even as the United States issued emergency authorization for such therapies.

"There are a number of clinical trials going on around the world looking at convalescent plasma compared to the standard of care," Soumya Swaminathan, WHO chief scientist, said.

© Reuters. FILE PHOTO: Convalescent plasma from a recovered coronavirus disease (COVID-19) patient at Bloodworks Northwest during the outbreak in Seattle

"Only a few of them have actually reported interim results...and at the moment, it's still very low-quality evidence," she told a news conference.

Latest comments

FDA is under control of Trump.
*sits back munching popcorn, playing dark souls, waiting patiently for market to correct*
Why isn't this in the 5 things to know in the market??
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.